European VC Funds

Credo Ventures is a Prague-based venture capital firm founded in 2009, focused on early-stage investments in technology startups within Central and Eastern Europe. They invest in a variety of sectors, including AI, medtech, edtech, and software. Their portfolio includes notable companies like Eleven Labs, Upheal, and Mewery. Credo Ventures typically invests in pre-seed and seed stages, with initial investments ranging up to €5 million. They currently manage €250 million across four funds, with their latest fund being €75 million. Their strategy is to back passionate founders from the ideation stage through to achieving product-market fit and beyond, providing both financial support and strategic guidance. The leadership team includes experienced partners like Jan Habermann, Lukas Hurych, and Vladislav Jez, who bring extensive experience in entrepreneurship and venture capital. They focus on building long-term relationships with founders and helping them navigate the challenges of scaling their businesses globally. Geographically, Credo Ventures targets startups from Central and Eastern European countries such as the Czech Republic, Poland, Hungary, and Romania, aiming to support their expansion into global markets.

Crescendo Venture Partners (CR-VP) is a Tel Aviv-based venture capital firm focused on investing in early-stage companies that leverage next-generation technologies such as Big Data, AI, and Machine Learning. Founded by a team of seasoned venture capitalists with over 75 years of combined experience, CR-VP seeks to partner with ambitious entrepreneurs who aim to build sustainable, profitable businesses that can become category leaders in their respective industries. The firm emphasizes supporting startups that offer simple, scalable solutions to complex problems across substantially-sized markets. CR-VP's approach involves not only providing capital but also offering strategic support to help companies navigate the journey from inception to exit. CR-VP's portfolio includes notable companies like WalkMe, which went public, and Cyota, which was acquired by RSA. The firm also collaborates with the Geneva-based Crescendo Group, providing access to untapped sources of capital and broadening the reach to European, LATAM, and Asian markets.

Crescent Capital, founded in 1995 and headquartered in Belfast, Northern Ireland, is a venture capital firm that focuses on early-stage and growth investments in technology, life sciences, and manufacturing sectors. They have a strong track record of supporting innovative SMEs and high-growth potential companies. Some of their notable investments include GoReport, a market-leading digital building surveying software developer, and Twiga Foods, a prominent food distribution platform in Kenya. Crescent Capital has also invested in other impactful companies such as Replify, Datactics, and Voscuris. Their recent funding initiatives include the Crescent Capital IV fund, which offers investments of up to £5 million to support companies in their growth phases​​. Crescent Capital's strategic approach involves not only providing financial support but also leveraging their expertise and network to help portfolio companies scale and succeed in global markets. The firm is committed to fostering entrepreneurship and driving private sector growth, contributing significantly to the local and international business ecosystems​.

Crescite Ventures is a New York-based early-stage venture capital firm operating as the venture arm of dSA Capital, with an additional presence in Miami. Founded in 2018, the firm backs startups in the United States and Sweden at pre-seed, seed, and Series A stages, with a particular focus on companies building technology solutions for Latin American markets. The fund's geographic thesis — US or European-based startups addressing the underserved Latin American opportunity — gives it a distinctive angle in the early-stage market. Crescite invests $1 million to $20 million across rounds, with primary concentration in fintech, AI, blockchain, data science, and adjacent software categories. The portfolio of 16 companies includes one unicorn, signaling that the firm's thesis on Latin American digital infrastructure has produced at least one breakout outcome. The fund's technology focus areas reflect the underlying belief that financial services modernization, AI-enabled products, and data-driven platforms will define the next wave of growth across the region. The firm's combination of New York access to US capital networks and an explicit Latin American market focus positions it to support portfolio companies with both growth capital and cross-border commercial strategy. Crescite works closely with founding teams to help them navigate the complexities of building globally scalable businesses with genuine regional impact.

Crew Capital is a community-driven venture capital firm founded in 2020 by Brandon Deer and Daniel Dines, both prominent figures from UiPath. The firm is headquartered in San Francisco, California, and focuses on providing active operational support to portfolio companies, setting it apart from traditional VC models. Crew Capital's first fund, raised in 2021, amounted to $50 million. This fund supports investments in early-stage startups, helping them scale through a network-driven approach. Crew Capital invests across various regions including the U.S., Europe, Israel, and Latin America, targeting transformative businesses that have the potential to redefine their respective industries. Their portfolio includes notable companies such as BetterUp, Chainalysis, Cedar, and Spring Health. The firm's unique approach involves active involvement from founders who have significant experience in scaling successful companies, ensuring portfolio companies receive unparalleled support and guidance​.

Crista Galli Ventures is a London-based evergreen venture capital fund founded in 2019, operating as the healthtech investment arm of IPQ Capital — the family office of Dr Fiona Pathiraja and Søren Fryland Møller, who serve as the fund's two partners. Also active from Copenhagen, the firm focuses on European healthtech startups led by clinicians and domain experts, investing at the nexus of biology, technology, and medicine. The evergreen structure allows the fund to maintain long-term positions and support founders through extended development timelines typical of healthcare innovation. Crista Galli invests at Seed and Series A stages, writing checks from €100,000 to £3 million, across digital health, AI-enabled clinical tools, medical devices, and personalized medicine. With 48 investments across the UK, Germany, France, Spain, and the Netherlands, the portfolio includes Bugbiome, Kanjo Health, CardiaTec, Inne, Keleya, Leda Health, and aeon — spanning fertility, cardiology, digital therapeutics, and wearable health monitoring. The firm's clinical and scientific credibility is central to its value proposition. Dr Pathiraja's background as a physician-investor enables Crista Galli to evaluate clinical validity and adoption potential in ways that purely financial investors cannot. The fund backs companies with strong user adoption potential and genuine capacity to solve real-world healthcare problems at scale.

Critical Ventures is a Portuguese venture capital firm founded in 2011 and headquartered in Coimbra, Portugal. The firm invests in game-changing companies with the potential to transform how the world uses technology, with particular focus on IoT, automation and digitalization, cybersecurity, AI and machine learning, and user experience design. What distinguishes Critical Ventures is that its partners are technology entrepreneurs themselves — João, Gonçalo, and Pedro have been with the firm since its founding in 2012 and work side by side with portfolio companies, bringing both funding and direct technical expertise. The firm invests from pre-seed through Series A, writing checks of $250,000 to $3 million. The portfolio of 13 investments includes RunSafe Security in cybersecurity, Twinzo in industrial IoT, and Kirontech in AI-powered technology. With roughly equal representation across security, hardware and IoT, AI, and software, the portfolio reflects Critical Ventures' belief that the most transformative technology companies operate at the convergence of these disciplines rather than within any single vertical. Critical Ventures takes a global investment perspective while maintaining its European operational base. The firm's founding team of seasoned technology operators brings real-world experience in building and scaling tech products, making their engagement with founders substantive rather than advisory. Portfolio companies benefit from the team's technical credibility in customer and partner conversations as well as in product development decisions.

Cross Creek is a venture capital firm based in Salt Lake City, Utah, with a distinctive focus on late-stage growth companies that are poised to transition from private to public markets. Founded by Karey Barker in 2006, originally within Wasatch Advisors, the firm became an independent entity in 2012. Cross Creek's strategy revolves around investing in companies with proven business models and established market potential, capturing value as they scale towards IPOs or strategic acquisitions. Their portfolio includes notable names like GitLab, Dataminr, and Pindrop, reflecting their investment in sectors such as enterprise software, healthcare, and consumer tech. With over 100 investments, 27 IPOs, and 36 M&A exits, Cross Creek's approach combines public market insights with venture capital expertise, enabling them to bridge the gap between late-stage funding and public exits. The firm is headquartered outside the typical venture hubs, giving it a unique perspective. According to Barker, being based in Utah allows Cross Creek to avoid groupthink and strategically identify underappreciated opportunities, leveraging the burgeoning "Silicon Slopes" tech ecosystem. They believe that Utah's growing innovation culture, combined with their focus on diversity in hiring and thought leadership, sets them apart. Cross Creek’s ability to invest alongside top-tier venture funds while also making direct investments has allowed them to manage over $1.3 billion in assets, making a substantial impact on the venture ecosystem​.

Cross Ocean Ventures (COV) is an early-stage venture capital firm founded in 2022 with a dual presence in San Diego, California and Amsterdam, Netherlands. Co-founded by Milan Saes, Serhat Pala, and Zeynep Ilgaz — a team with over 100 years of combined experience in business management, commercialization, and investment — the firm focuses exclusively on ambitious technology companies that have originated in Europe or Israel and are ready to expand into the US market. COV positions itself as the premier fund for international founders with global ambitions. The firm leads rounds and writes checks of $100,000 to $750,000 at pre-seed through Series A, concentrating on digital health, B2B SaaS, and digital identity. The portfolio of 11 companies includes FenixPyre, Alpha3D, and HoustonBionics, spanning cybersecurity, AI-generated content, and medical technology. COV's specific goal is to help European and Israeli startups position for Series A funding from US investors within 12 to 24 months of initial investment, providing hands-on commercial and strategic support through that transition. The firm invests across a wide European geography including Israel, Germany, Belgium, Estonia, Finland, Ireland, the Netherlands, Norway, Turkey, and the UK. Its transatlantic structure gives portfolio companies direct access to US networks from their earliest growth stages, addressing the market entry challenge that derails many technically strong international startups.

Crossbeam Venture Partners is a venture capital firm that specializes in investing in pre-seed and Series A startups focused on the future economy. With a strong emphasis on platform economies, fintech, emerging asset classes, and new media, Crossbeam supports innovative companies poised to reshape industries. Notable investments include startups like Spotter, Acquco, and QuickNode, reflecting the firm’s commitment to scalability and high-growth potential. Founded by Ali Hamed and Chris Ryan, Crossbeam goes beyond traditional investing by offering founders strategic guidance, industry connections, and hands-on support. The firm is known for its deep involvement with portfolio companies, helping them navigate the complexities of scaling businesses in competitive sectors such as Web3, remittances, and the creator economy. By focusing on high-potential business models and leveraging its team’s operational expertise, Crossbeam has played a pivotal role in guiding startups through their growth phases. Crossbeam recently raised a $70 million fund, which strengthens its ability to support early-stage companies focused on long-term value creation. The firm operates primarily out of New York and San Francisco, but its investment reach extends globally, particularly in sectors like fintech and logistics. With a reputation for collaboration and adaptability, Crossbeam continues to support visionary founders aiming to redefine the economic landscape.

Crowberry Capital, a venture capital firm based in Reykjavik, Iceland, and Copenhagen, Denmark, focuses on seed and early-stage investments in the Nordic region. Founded by Helga Valfells, Hekla Arnardottir, and Jenny Ruth Hrafnsdottir, the firm aims to support innovative and high-potential startups across various sectors, including technology, digital health, and gaming. The firm has raised Iceland’s largest VC fund, a $90 million vehicle, which supports their mission to back diverse and bold entrepreneurs. Crowberry Capital’s portfolio includes notable companies such as Mainframe Industries, a gaming studio developing cloud-native social sandbox MMO Pax Dei; Lucinity, an AI-powered anti-money laundering platform; and Garden.io, which automates cloud development processes. Other investments include companies like Dreamdata, which focuses on B2B revenue attribution, and Kind, a provider of digital communication tools for healthcare providers​. Crowberry Capital prides itself on a strong follow-through philosophy, offering not only capital but also strategic support to help startups scale. Their approach has attracted significant interest from US VC funds at the Series A stage, highlighting the collaborative and robust nature of the Nordic startup ecosystem​.

Curiosity VC is a community-powered venture capital firm founded in 2021 and based in Amsterdam, Netherlands. Led by experienced operator-investors Herman Kienhuis and Maurice Beckand Verwee as co-founding Managing Partners, the firm focuses on early-stage investments in talented, diverse founding teams across the Benelux, Nordics, and Baltic regions who are building the next generation of AI-driven global software companies. The firm's community of 23 team members includes entrepreneurs, expert advisors, and investors who actively contribute to sourcing and portfolio support. Curiosity leads rounds and writes checks of €500,000 to €1 million at seed and Series A stages, focusing on B2B software with AI applications across fintech, proptech, legaltech, enterprise software, marketing technology, cybersecurity, energy, and climate technology. The firm has made 44 investments — spanning Belgium, Denmark, Estonia, Finland, Lithuania, the Netherlands, Norway, and Sweden — with 3 new investments added in the most recent 12-month period. The firm's community-powered model is a deliberate structural choice: Curiosity draws on an engaged network of founders and operators to extend its deal sourcing, due diligence, and portfolio support beyond what a small investment team could accomplish alone. The firm's mission — supporting entrepreneurs building software companies to serve the world, not simply consume its resources — reflects a values orientation that runs through both its sector focus and founder selection criteria.

Current Ventures is a fintech-focused venture builder founded in 2018 and headquartered in Munich, Bavaria, with an additional office in Naples, Florida. Rather than investing in externally originated companies, the firm works alongside exceptional co-founders and teams to build innovative fintech ventures from the ground up, placing itself at the center of the broader fintech revolution reshaping how people and institutions interact with money. Current Ventures' team of 11 to 50 professionals combines entrepreneurial experience with deep domain expertise in financial services. The firm's ventures specialize in state-of-the-art B2B software and SaaS solutions for banks, fintechs, and payment providers operating in the United States and Europe. Core areas of focus include regulatory compliance technology, digitalization and modularization of financial services, and tools for addressing the systemic cost pressures facing legacy financial institutions. With 13 portfolio companies spanning fintech, SaaS, and software, Current Ventures leads its positions and typically deploys $1 million to $10 million per engagement. Current Ventures operates as a venture studio rather than a traditional fund, meaning founders gain a hands-on operational partner who brings shared infrastructure, talent networks, and domain knowledge alongside capital. The firm's Munich-to-Florida presence reflects its ambition to build fintech companies that scale across both the European and North American markets from inception.

Cybernetix Ventures is a venture capital firm focused on investing in early-stage robotics, automation, and artificial intelligence (AI) startups. Based in Boston, the firm invests globally, targeting companies that apply innovative automation technologies across various industries. Their portfolio includes cutting-edge startups such as Raise Robotics, which develops robots to improve safety and efficiency on construction sites, and Realtime Robotics, which creates processors for rapid, collision-free robot movements in unstructured environments. Cybernetix’s investment strategy focuses on companies in sectors like healthcare, industrial automation, and construction, aiming to revolutionize traditional industries through robotics and AI. Other notable portfolio companies include Kewazo, which offers robotic solutions to streamline construction processes, and Bionomous, which combines AI and micro-engineering to automate biological entity sorting, a breakthrough for healthcare labs. The firm is led by experienced partners like Mark Martin, who brings over 25 years of leadership in industrial and tech sectors. Cybernetix Ventures is known for its deep engagement with its portfolio companies, providing strategic support alongside capital to drive scalable growth in the rapidly evolving world of automation and robotics.

CyLon Ventures is a specialized venture capital firm focused on cybersecurity and resilience technologies. Originally launched as a global cybersecurity accelerator in 2015, CyLon has shifted its strategy to invest directly in startups, providing not just capital but also strategic guidance to help companies tackle complex security challenges. Their investments span a broad range of security domains, including cloud security, network security, and threat intelligence, aiming to support innovation that underpins the safety of future technologies. Headquartered in Witney, United Kingdom, CyLon Ventures was co-founded by Grace Cassy, Jonathan Luff, and Alex van Someren. The founders bring extensive backgrounds in national security, technology, and investment, leveraging their expertise to guide startups in navigating the complexities of the cybersecurity landscape. Jonathan and Grace previously served as advisors to UK Prime Ministers, while Alex is known for his pioneering work in internet security and venture capital. CyLon's typical investment ranges from €100k to €1.5M, focusing on early-stage companies at the pre-seed to Series A/B levels. Their strategy is global, with past involvement in regions including Europe, Asia, and the Middle East. They continue to play a pivotal role in fostering the next generation of cybersecurity leaders, helping startups build robust commercial partnerships and navigate regulatory environments. Through a combination of funding and hands-on support, CyLon ensures that emerging companies can scale effectively while addressing critical security concerns.

D-Ax Corporate Venture Capital is a Stockholm-based investment partnership founded in 2013 between Axel Johnson AB, one of Sweden's largest retail and trade conglomerates, and RECAPEX, a Nordic investment company specializing in digital businesses. The collaboration pairs Axel Johnson's century-long experience in traditional retail, trade, and services with RECAPEX's expertise in digital commerce and its network of technology-driven operators, creating a distinctive strategic investor for Northern European digital retail startups. D-Ax invests in Seed through Series B rounds, targeting digital startups in the retail space that have demonstrated proven business models and a measurable level of revenue. The firm writes checks of $1 million to $10 million, concentrating on e-commerce, payment solutions, logistics, marketing technology, data analytics, and online marketplace models. The portfolio of 13 investments includes notable exits in Otovo, a solar energy marketplace, and Ztory, a digital magazine subscription platform — demonstrating the fund's reach across both retail-adjacent sustainability and media commerce. D-Ax's corporate structure gives portfolio companies more than capital: they gain access to Axel Johnson's procurement relationships, retail distribution networks, and operational infrastructure across Northern Europe. This strategic value is particularly relevant for companies in trading, logistics, and digital services where enterprise customer relationships can accelerate commercial traction significantly faster than organic business development.

d.ventures is a Cologne-based investment firm founded in 2018 with an additional office in Vienna, Austria, that invests in tech-driven startups with product-market fit across Europe, the United States, and the UAE. The team is composed of founders, entrepreneurs, developers, designers, and business angels — a mix that gives the firm an operator-oriented perspective on the companies it backs and enables genuine hands-on engagement with portfolio teams during critical growth phases. The firm writes checks of €50,000 to €2 million from pre-seed through Series B, with flexibility to participate in pre-IPO rounds as well. Its sector focus spans B2B SaaS, deep technology, fintech, and e-commerce, with 11 investments spanning Germany, Austria, Belgium, Bulgaria, Denmark, Finland, France, Italy, and additional European markets, as well as the UAE and Canada. The breadth of its geographic reach reflects the team's international entrepreneurial backgrounds and its willingness to back strong product teams regardless of location. d.ventures' differentiation is rooted in its team's founder-first perspective: the partners have built companies themselves and invest with what they describe as love and commitment alongside their capital. This orientation translates into a hands-on partnership model where the firm engages actively on product strategy, business development, and team building rather than maintaining a purely advisory relationship with portfolio companies.

Da Vinci Capital is a private equity firm founded in 2007, specializing in mid-market, high-growth investments. Based in London, it focuses on emerging markets, particularly in Central and Eastern Europe (CEE) and the Commonwealth of Independent States (CIS). The firm primarily targets sectors like financial infrastructure, IT services, and consumer solutions, investing in companies poised to become market leaders through innovative technology and scalable business models. Da Vinci typically invests $10-20 million in equity per deal, sometimes acquiring larger stakes through co-investment partnerships. The firm is known for its hands-on approach, providing strategic guidance, corporate governance support, and access to capital markets. Their goal is to grow portfolio companies into global players, with successful exits through strategic sales or IPOs. The firm’s portfolio includes notable investments like EPAM Systems, which successfully exited via an IPO, and DataArt, a global software engineering firm. Da Vinci also emphasizes environmental, social, and governance (ESG) factors in its investment decisions, avoiding sectors like oil and gas, and ensuring ethical labor practices across its portfolio. Led by founder Oleg Jelezko, Da Vinci’s team combines expertise in finance, technology, and entrepreneurship, with a focus on expanding companies' international reach.

DAA Capital Partners is a Geneva-based venture capital firm, established to invest in early-stage ventures across technology, consumer goods, and health sectors. Founded with a focus on sustainable growth, DAA Capital provides both financial capital and strategic support to innovative startups in Europe. The firm's investment strategy revolves around Seed and Series A funding rounds, helping young companies scale their operations and realize their potential. Some of DAA Capital’s notable investments include Creal, a company revolutionizing display technologies, Tinamu Labs, which focuses on drone automation, and Smeetz, an AI-driven marketplace platform. The firm leverages its deep industry expertise and global network to offer more than just capital, acting as a strategic partner to help its portfolio companies grow effectively. With a strong commitment to driving innovation, DAA Capital Partners continues to make impactful investments across Europe, emphasizing long-term value creation and responsible growth.

Dale Ventures is a Dubai-based investment holding group and venture capital firm founded in 2017, with offices in Costa Rica, Panama, Hong Kong, the United Kingdom, Dubai, and Singapore. Led by CEO Hilt Tatum IV, the firm was established and is operated by entrepreneurs who partner directly with management teams at industry-leading companies to accelerate growth. Dale Ventures prioritizes ventures led by high-potential entrepreneurs whose teams possess deep domain expertise, technical knowledge, and relevant industry experience across their target sectors. The firm invests at Seed through Series B stages, deploying checks of $1 million to $10 million across financial and business services, technology and media, real estate, consumer, and retail. Its portfolio of 11 companies spans financial services, commercial services, media, and IT — reflecting the firm's broad investment mandate across both developed and emerging market geographies. The global office footprint across the Middle East, Asia, Europe, and the Americas enables Dale Ventures to source deals across multiple high-growth regions and provide portfolio companies with genuine cross-border commercial support. Dale Ventures operates at the intersection of traditional investment holding and active venture partnership, blending corporate investment discipline with founder-oriented engagement. The firm's presence in Dubai positions it at the center of the Gulf region's growing technology and entrepreneurship ecosystem, while its network across Singapore, Hong Kong, and London extends its reach into Asia-Pacific and European markets.

Danfoss Ventures is the corporate venture capital arm of Danfoss A/S, a family-owned global industrial company headquartered in Nordborg, Denmark that was founded in 1933 and generates approximately €11 billion in annual revenue. The fund invests in startups aligned with Danfoss's core industrial mission: driving energy efficiency, decarbonization, and sustainable innovation in support of the Paris Agreement goals. As a CVC backed by a family-owned corporation, Danfoss Ventures brings a longer investment horizon than traditional closed-end funds, reflecting the parent company's orientation toward durable industrial value creation. The fund deploys checks in the $3 million to $10 million range from seed through growth stages, focusing on cleantech, energy, and hardware and IoT. With approximately 12 investments and 4 exits, portfolio companies include Nelumbo in advanced energy-efficiency coatings, LineStream Technologies in motor optimization, and Nanotron Technologies in location and sensor solutions. The firm co-invests alongside partners including Zouk Capital, U.S. Venture Partners, and PolyTechnos Venture Partners. Nelumbo was the fund's most recent exit, completed in April 2025. Danfoss Ventures' investment thesis centers on applying the parent company's deep application knowledge in heating, cooling, drives, and power solutions to support portfolio companies tackling industrial innovation and sustainability challenges. Founders benefit not just from capital but from access to Danfoss's global engineering and commercial networks across industrial customer segments.

Danone Ventures, the corporate venture arm of Danone, is at the forefront of investing in groundbreaking startups within the food and beverage industry. Notable investments include Farmer's Fridge, Harmless Harvest, and Michel et Augustin, demonstrating their commitment to supporting innovative brands that push the boundaries of health and sustainability. With a strategic focus on early-stage companies, Danone Ventures targets sectors such as plant-based products, sustainable food systems, and personalized nutrition. Their geographic reach spans across North America, Europe, and increasingly into emerging markets, showcasing a global outlook with a local touch. Danone Ventures employs a proactive investment strategy, often taking significant stakes and leading funding rounds. They typically invest between $1M and $10M, providing not just capital but also leveraging Danone's extensive resources to help startups scale. The firm has shown consistent activity, with recent investments in companies like Nature’s Fynd and Ready, Set, Food!, highlighting their commitment to innovation and sustainability. The team at Danone Ventures includes experts like Laurent Marcel and Emmanuel Faber, who bring deep industry knowledge and a passion for transforming the food landscape. Startups looking to partner with Danone Ventures should emphasize their innovative approach and alignment with Danone's mission of bringing health through food to as many people as possible. Being approachable and showcasing strong market potential are key to gaining their interest. Danone Ventures is dedicated to fostering a healthier world through strategic and impactful investments.

Daphni Ventures, based in Paris, was founded in 2016 and focuses on early-stage investments with a European DNA and strong international ambition. The firm aims to support companies that contribute to making the world a better place through innovative and disruptive models, emphasizing social and environmental sustainability. Daphni's investment thesis revolves around empowering founders to create a sustainable future by leveraging deep tech and innovation. The firm has made over 80 investments and has seen multiple successful exits, including Shine.fr, Masteos, and Foxintelligence. Their portfolio includes a wide range of companies such as ZOE, a personalized nutrition platform; Double, a remote executive assistant service; and Masteos, a full-stack real estate agency. They also back companies in sectors like edtech, fintech, and health tech, supporting ventures that focus on the circular economy, upcycling, social inclusion, and the future of work. Daphni operates three main investment vehicles: Purple, Yellow, and Dastore, each focusing on different areas of innovation and sustainability. Their approach involves not only providing capital but also offering operational support and access to a community of experts to facilitate collaboration and knowledge-sharing among their portfolio companies.

DART Labs & Ventures is a Zurich-based early-stage venture capital firm founded in 2017 by Sophie Lamparter and Arijana Walcott, both serving as Managing Partners, with a satellite office at swissnex San Francisco. The firm invests in European academics, innovators, and early-stage entrepreneurs working on breakthrough technologies for health and climate impact, with a notable 50% diversity factor across its portfolio. DART provides each portfolio company with a tailored 12-month acceleration program designed specifically to help European startups navigate and expand into the US market. DART leads rounds and deploys $200,000 to $300,000 at pre-seed and seed stages. The health portfolio includes Bea Fertility in at-home fertility care, BottNeuro in digital brain health, Impli in implantable bio-sensors, Perivision in AI-powered vision care, Resmonics in remote lung monitoring, Una Health in blood sugar tracking, and Xsensio in on-skin bio-sensors. The climate portfolio spans Fluidsolids in bioplastics, Gaeastar in sustainable cups, Inergio in mini fuel cells, and Orbillion Bio in cultivated meat. Across 15 investments, the firm has recorded 1 exit (VAY, September 2021). A 30-plus-member advisory network spanning Google, Meta, Stanford, ETH Zurich, Daimler, Takeda, and True Ventures provides portfolio companies with access to corporate partners, academic institutions, and top-tier investors. Venture Partner Priska Roesli leads the firm's finance function. DART also operates Vitamin°C, a female-led initiative focused on climate change mitigation.

Dawn Capital, founded in 2007 and based in London, focuses on investing in early-stage B2B software companies across Europe. The firm manages multiple funds, with a strong emphasis on sectors such as fintech, data and analytics, security and privacy, and enterprise software. Dawn Capital has a robust portfolio featuring companies like Mimecast, iZettle, and Tink. Notable recent investments include Omi, a platform for real-time experiences, and Cover Genius, an insurtech startup. The firm has achieved several successful exits, including the sale of Tink to Visa and the acquisition of Granulate by Intel. Dawn Capital is known for its deep industry expertise and active support of its portfolio companies, helping them scale from local champions to global leaders.

Day One Capital, founded in 2011, is a venture capital firm based in Budapest, Hungary, focusing on early-stage technology startups primarily in the Central and Eastern European (CEE) region. They are known for their investments in B2B software companies, leveraging the region's strong talent pool to support technology-driven founders. Day One Capital has built a diverse portfolio across various industries, including AI, fintech, and logistics. Notable investments include Turbine AI, which uses simulated cell technology to enhance drug discovery; Webshippy, a logistics and fulfillment service provider; and Volteum, a company aiding electric vehicle fleet management. They have also backed companies like Colossyan, which specializes in generative AI for video editing, and Commsignia, a leader in automotive IoT​. Their typical investment range is from €300k to €1.5 million for seed and Series A rounds. They have been instrumental in helping companies scale globally, providing not only capital but also strategic support and mentorship from their experienced team, which includes former government officials and seasoned investors​​. Day One Capital continues to foster growth and innovation within the CEE region, contributing significantly to the local startup ecosystem and helping companies achieve successful exits, such as AImotive's acquisition by Stellantis and NOW Technologies' acquisition by Sunrise Medical​​.

DB1 Ventures is the corporate venture capital arm of Deutsche Boerse Group, one of Europe's leading exchange organizations, founded in 2016 and headquartered in Frankfurt, Germany. The firm focuses exclusively on strategic investments in fintech startups building capital markets infrastructure, targeting innovations that are core or adjacent to Deutsche Boerse's strategy: trading technology, post-trade services, data analytics, regulatory technology, and blockchain-based financial infrastructure. The fund deploys EUR 5 million to EUR 25 million per investment, taking minority or significant minority stakes in Series A through growth-stage companies across Europe and the United States. DB1 leads rounds and has made 25 investments with 4 exits to date. Notable portfolio companies include Caplight in pre-IPO secondary transactions, Primary Portal — in which DB1 led the Series A in July 2024 — in primary capital markets platforms, Next Gate Tech in post-trade technology, OptimX Markets in electronic trading, TruMid in electronic bond trading, and Forge Global, which exited via SPAC in 2022. The team is led by Markus Hablizel as Head of DB1 Ventures, supported by Investment Principals Monika Fuchs and Christoph Osburg. DB1 Ventures' differentiation is structural: portfolio companies gain not just capital but direct connectivity across the Deutsche Boerse Group ecosystem, including access to the group's exchange relationships, post-trade infrastructure, regulatory networks, and enterprise customer base across European financial markets. For fintech companies building in capital markets, few investors can match this level of strategic reach.

DBTH Capital Ventures is a London-based venture capital firm founded in July 2018 by Virginie Berger, a music and entertainment executive with more than 20 years of experience across companies including Microsoft, NRJ, Omnicom, and MySpace France. The firm's name derives from Don't Believe The Hype, Berger's long-running consulting brand in the music industry -- a signal of its contrarian, specialist orientation. DBTH Capital focuses exclusively on rights technology and content technology, with emphasis on music tech, entertainment rights infrastructure, artificial intelligence applications, and blockchain within the creative industries. The firm raised its debut fund, DBTH Capital Fund I, at approximately EUR 35 million (USD 38.5 million) in a first close announced in September 2019, established in partnership with a US-based family office controlling nearly $5 billion in assets. The fund writes checks of $500,000 to $5 million at seed and Series A stages, targeting companies building infrastructure for digital rights management, royalty distribution, music licensing, and AI-powered content tools. Seven investments span media and entertainment, AI, Web3, and software. Berger's position at the intersection of music industry leadership and technology investment gives DBTH Capital access to key ecosystem partners -- labels, managers, publishers, and streaming platforms -- that purely financial investors cannot replicate. The firm forms strategic partnerships with these stakeholders to support portfolio companies in navigating the complex rights and licensing landscape that defines the music technology sector.

DC Thomson Ventures (DCT Ventures) is the corporate venture capital arm of D.C. Thomson & Co. Ltd., a private, family-owned international media group headquartered in Dundee, Scotland with a London office on Fleet Street. Founded in 2013, the firm specializes in digital media and technology sectors, driving innovation and growth through strategic investments and acquisitions. DCT Ventures has invested in approximately 13 companies, recorded 3 exits, and counts both a unicorn and a decacorn among its portfolio companies — a strong record for a CVC of its size. The fund invests from Series A through Series C with checks of $100,000 to $1 million, focusing on agtech, cleantech, media and entertainment technology, software, and e-commerce. Notable portfolio companies include Kando in water and wastewater management technology, which reached Series C in 2024; PlayCanvas, a cloud-hosted game development platform; CogBooks in adaptive learning; and Intelligent Growth Solutions in vertical farming. The portfolio also included Trax, an in-store retail execution technology company that achieved decacorn status before exiting in February 2026. DCT Ventures leverages DC Thomson's expertise across its operating businesses — which span publishing, digital media, education, retail, and broadcasting — to provide portfolio companies with strategic relationships and operational insight. The fund's data-driven, operator-first investment philosophy reflects the parent company's hundred-plus year history of building media businesses that adapt to technological change.

DCG Expeditions is the early-stage investment arm of Digital Currency Group (DCG), focused on supporting fintech and crypto founders building the next generation of financial services. Founded in 2021, and rebranded from Luno Expeditions, the firm primarily invests in pre-seed and seed-stage startups globally. With its headquarters in London, DCG Expeditions operates on a global scale, making investments across developed and emerging markets. The firm’s investment strategy is to provide early capital, typically between $50,000 and $250,000, while co-investing with other lead investors in various rounds. They focus on both traditional fintech companies, such as challenger banks, and crypto-native startups that are advancing the decentralized finance (DeFi) space. Their portfolio includes companies like Kotani Pay and Caliza, highlighting their commitment to innovative fintech solutions in regions like Africa and beyond. DCG Expeditions prides itself on leveraging the vast network and resources of its parent company, DCG, to support founders in areas like compliance, scaling, and market entry. The team is led by CEO Jocelyn Cheng and is known for backing startups that are creating a more inclusive and open financial system.

Dedicated is a Luxembourg-based venture capital investment boutique founded in 2019 by Martin Tabery, Olivier Tabery, and Benjamin Tillier, operating from Grand-Rue 30 in Luxembourg. The firm sources and structures high-potential deals for private investors, positioning itself as a curator of exclusive allocations in oversubscribed rounds rather than a traditional blind-pool fund. Dedicated manages multiple fund vehicles including Dedicated VC I, II, and III as well as a dedicated fintech vehicle, investing EUR 1 million to EUR 3 million from Series A through pre-IPO rounds globally. With 30-plus investments, the portfolio spans fintech, spacetech, AI, climate technology, proptech, and quantum computing. Notable investments include Revolut, SpaceX, xAI, Klarna, Airbnb, OpenAI, Aerospacelab, Passbolt, Perlego, and ClearSpace in space debris removal. Additional holdings include Solaris, Kraken, Lendable, Opendoor, Atai Life Sciences, and Rain. Investment Analyst Valerian Meunier supports the leadership team on deal execution and portfolio monitoring. Dedicated's model gives private investors a high degree of autonomy: rather than committing capital to a blind pool, LPs can select specific deals they wish to participate in, retaining discretion over individual allocation decisions. This structure reflects the firm's belief that sophisticated private investors benefit from curated access to institutional-quality deal flow at meaningful check sizes, without sacrificing the transparency and control that direct deal participation provides.

Deep Science Ventures (DSV) is a London-based venture studio founded in 2016 that specializes in building science-driven startups across four key sectors: agriculture, computation, climate, and pharmaceuticals. DSV's approach is unique in that it combines scientific knowledge with entrepreneurial expertise to create high-impact ventures from scratch. They partner closely with founder-scientists to tackle some of the world's most pressing challenges, such as reversing global warming, developing curative therapeutics, and advancing computational technologies. DSV's portfolio includes a diverse range of companies, such as Mission Zero Technologies, which focuses on energy-efficient direct air capture of CO2, and Neobe Therapeutics, which is engineering bacteria to improve the efficacy of cancer immunotherapy. These ventures reflect DSV's commitment to creating transformative solutions that are both scientifically rigorous and commercially viable. The firm's model emphasizes de-risking ventures through deep technical and market analysis before significant capital is committed. This methodical approach ensures that the startups they create have a strong foundation for long-term success.

Deepbridge Capital, established in 2010 and headquartered in Chester, UK, focuses on providing growth capital to companies in the technology, life sciences, and renewable energy sectors. Their investment approach emphasizes supporting innovative and high-growth potential companies through various tax-efficient investment opportunities. Deepbridge Capital's portfolio includes a diverse array of companies. Notable investments are in firms like AlgaeCytes, which specializes in producing high-quality EPA oils from algae, and VoxSmart, which provides compliance management solutions for banks. They have also invested in promising startups like Thalia Design Automation, an AI-driven EDA platform, and Ibis Vision, a cloud-based vision testing software for the optical industry. The firm has made 168 investments and has seen 101 exits, showcasing their experience and success in nurturing companies to achieve significant milestones. Deepbridge Capital also supports companies through initiatives such as the Deepbridge Technology Growth EIS Fund and the Deepbridge Innovation SEIS Fund, offering financial backing and strategic guidance to early-stage businesses. The Deepbridge team, led by Managing Partner Ian Warwick, is known for their commitment to fostering innovation and growth across their investment sectors. For more information about their investments and strategic approach, you can visit their official website.

The DeepTech & Climate Fonds (DTCF) is a German venture capital fund aimed at supporting growth-stage startups working on transformative technologies in sectors such as deep tech and climate tech. Established in 2023, the fund has a capital pool of €1 billion, sourced from Germany’s Future Fund and the European Recovery Program. It focuses on companies developing solutions in fields like Industry 4.0, quantum computing, AI, and clean energy technologies. DTCF primarily invests in companies that require long development cycles and substantial capital, providing them with the resources to scale their innovations across Europe. The fund works as an anchor investor, partnering with institutional investors, family offices, and private capital to ensure that these companies can achieve commercial success and contribute to a climate-neutral economy. Led by Dr. Elisabeth Schrey and Tobias Faupel, DTCF has already made notable investments in companies like Membion, which focuses on wastewater recycling, and Cylib, a battery recycling startup. The fund's mission is to drive systemic change by investing in technologies that will reshape industries and contribute to sustainability across the European tech landscape​.

Deeptech Seed Fund is a Dublin-based venture capital firm focused on supporting early-stage deep-tech startups across Europe. Established by Pearse Coyle in 2018, the fund specifically targets ventures that have achieved significant scientific or technological breakthroughs and are starting to demonstrate global market potential. Their focus spans a broad array of sectors, including artificial intelligence, blockchain, robotics, sustainability, and IoT, although they avoid investments in life sciences​. The fund operates with an investment thesis built around market validation. Before committing capital, Deeptech Seed Fund ensures that startups have connected with potential customers and obtained valuable feedback. They then collaborate with international later-stage investors to provide these promising ventures with robust follow-on funding. This approach ensures startups receive the right type of funding from the beginning, positioning them for long-term success in global markets​. With investments typically starting at $100,000, Deeptech Seed Fund takes an active role in helping startups commercialize their innovations. Notable companies in their portfolio include Qoitech, a Swedish company developing energy optimization solutions, and Signapse, which specializes in AI-driven real-time sign language translation. The fund also emphasizes deep partnerships with incubators and innovation programs to scout cutting-edge research-based spinouts, further nurturing the commercialization of scientific advancements. By providing both capital and strategic support, Deeptech Seed Fund is instrumental in helping European deep-tech startups bridge the gap between research and market.

DeepTech Ventures is an early-stage venture capital firm headquartered in Pfaffikon, Switzerland, founded in 2018. The firm is an investment pioneer in the Web3 space, backing protocols, networks, and infrastructure projects across the full decentralized technology stack. Led by founder Alexander Christen — CEO of FiveT Fintech and formerly of Partners Group and SIX Swiss Exchange — alongside Managing Partner Daniel Curiger (ex-Goldman Sachs and UBS) and Crypto Research Analyst Florian Bitterli, the seven-person team brings deep roots in software development, finance, and economics. With 59 investments to date and typical check sizes between $100,000 and $1 million, DeepTech Ventures participates across blockchain, DeFi, NFTs, and DAO governance. The portfolio spans Layer 0/1 networks including Ethereum, Cosmos, Polkadot, Solana, and Avalanche; DeFi protocols such as Uniswap, Convex Finance, Curve, and Yearn Finance; NFT platforms including Decentraland and SuperRare; and infrastructure projects such as Lido, TheGraph, Arweave, and Filecoin. The firm takes an unusually active role in its investments beyond capital, engaging in governance voting, liquidity provision, keeper operations, and node operation within portfolio ecosystems. Investment instruments span equity, tokens, SAFEs, and SAFTs, giving the team flexibility to enter at the structure that best fits each project. The result is a fund deeply embedded in the ecosystems it backs rather than a passive observer.

Deerfield Management, a prominent investment firm based in New York City, is dedicated to advancing healthcare through strategic investments, information, and philanthropy. With over $14.6 billion in assets under management, Deerfield maintains a diverse portfolio of more than 200 private and public investments across biotechnology, pharmaceuticals, medical devices, healthcare services, and digital health industries​ . Notable portfolio companies include Graphcore, JFrog, and Netskope. The firm has a strong track record of supporting startups from early stages to mature companies, offering flexible funding models, including equity, debt, and joint ventures. Deerfield’s investment approach is characterized by deep operational support and a robust network of strategic partners and academic collaborations​ ​. Deerfield’s team comprises over 150 experienced professionals with expertise in various sectors of healthcare and finance, ensuring comprehensive support for their portfolio companies. The firm’s initiatives, such as the Deerfield Discovery and Development (3DC) and the Cure Campus, further highlight their commitment to fostering innovation and addressing complex health issues​​. The Deerfield Foundation, part of the firm’s philanthropic efforts, focuses on improving healthcare delivery, particularly for underserved populations, and has invested over $68 million in various health initiatives.

Delin Ventures is a UK-based, mission-driven venture capital firm that focuses on early-stage investments, specializing in two key areas: Life Sciences and the Future of Work & Learning. Established in 2015, the firm backs founders working on breakthrough technologies that can transform healthcare through cell therapies and the future of human work and learning. Delin invests in pre-seed and seed rounds, with typical ticket sizes ranging from €100,000 to €1.5 million, primarily in European startups. In the Life Sciences domain, Delin is committed to advancing cell therapy solutions that can either cure life-threatening diseases or transform them into manageable, chronic conditions. They also invest in the infrastructure necessary for the development and commercialization of these therapies. Notable investments include startups working on innovative therapeutics, medical services, and manufacturing technologies. In the Future of Work & Learning sector, Delin Ventures aims to unlock human potential by investing in technologies that shape the workforce of tomorrow. This includes HR tech, productivity tools, workforce development, and upskilling platforms. They provide hands-on support to founders, leveraging their deep operational expertise and extensive network. The team, led by founder Igor Linshits, includes experts from various industries, ensuring a strong focus on long-term impact. Delin's strategy is centered around making fewer, high-quality investments to ensure that they can offer exceptional support to their portfolio companies, which includes businesses like Fluidic Analytics, Vidsy, and Ori Biotech. The firm is highly selective, providing patient capital and working closely with founders to scale impactful solutions.

Delivery Hero Ventures (formerly DX Ventures) is the corporate venture capital arm of Delivery Hero SE, a publicly traded global food delivery platform headquartered in Berlin, Germany. Launched in January 2021 with initial capital of €50 million, the fund is fully backed by Delivery Hero SE and led by Managing Director Duncan McIntyre, who joined the parent company in 2014 and completed over 30 M&A transactions before leading the venture arm. The fund leads rounds and invests globally across food technology, on-demand services, AI, fintech, logistics, and sustainable innovation, writing checks averaging $5 million at Seed through Series B stages. The portfolio of 33 companies includes five unicorns, two IPOs, and three acquisitions. Notable holdings include Glovo (food delivery, acquired by Delivery Hero), Rappi (Latin American super app), Impossible Foods (plant-based meat), Ola (Indian ride-hailing), Toku (compensation management), and OneOrder (restaurant management). The fund's investment thesis centers on leveraging Delivery Hero's technical expertise and global network — spanning Europe, Southeast Asia, MENA, and Latin America — to help founders scale. Partner Brendon Blacker works alongside McIntyre to evaluate opportunities and support portfolio growth, with the team taking an engaged post-investment role in business development and market expansion.

Delta Partners is a Dublin-based venture capital firm specializing in early-stage investments in technology companies. Founded in 1994, the firm has a strong track record with over 140 investments and €1.8 billion in exit returns. Delta Partners focuses on seed and Series A investments, supporting companies from their foundation stage through to successful scaling and exits. They emphasize building solid company foundations and capital-optimizing cultures to increase the likelihood of success. The Delta team includes experienced partners like Dermot Berkery, Maurice Roche, Amy Neale (formerly of Mastercard), and Richard Barnwell (founder of Digit Games). They are committed to integrating sustainability risks into their investment process, ensuring that environmental, social, and governance (ESG) factors are considered throughout the lifecycle of their investments. Delta Partners operates with a partner-led approach, providing startups with direct access to senior-level experience from the first conversation. This hands-on support helps entrepreneurs navigate their journey from seed to Series A and beyond.

Demeter, a major European player in venture capital, private equity, and infrastructure, focuses on investments that drive the energy and ecological transition. Founded in 2005, Demeter manages €1.3 billion across its funds and has completed over 230 investments. The firm targets innovative startups, SMEs, and infrastructure projects, offering investments ranging from €1 million to €30 million. Notable investments include McPhy Energy, which specializes in hydrogen production, storage, and distribution technologies, and Ynsect, which produces environmentally friendly insect-based products. Demeter also supports companies like Sunna Design, which develops solar LED lighting solutions, and Sweetch Energy, a renewable energy firm focusing on osmotic energy. One of Demeter's significant initiatives is the recent launch of a €500 million fund in collaboration with EIT InnoEnergy. This fund aims to develop a resilient and diverse battery raw material supply chain for Europe, addressing the continent's growing demand for batteries and supporting the European Battery Alliance's goals. Demeter's investment strategy is driven by a commitment to sustainability, evident in their support for green projects like H2 Green Steel, the world's first integrated large-scale green steel plant. The firm's dedication to environmental responsibility is further reflected in their involvement in initiatives like the Climate Dividends program, which promotes sustainability across their portfolio companies.

Dentsu Ventures is the corporate venture capital arm of Dentsu Group, one of the world's largest advertising and marketing conglomerates. Founded in April 2015 and headquartered in Tokyo, Japan, the firm operates two funds totaling 20 billion yen (approximately $134 million): Global Fund I covering 2015 to 2025 and Fund II launched in 2021 with a ten-year life. Managing Partner Kotaro Sasamoto leads a team that includes General Partners Daiji Horibe, Kevin Hasegawa, and Daisuke Takemori. With 65 investments across the US, Europe, and Asia-Pacific, Dentsu Ventures backs companies from Seed through late stage in AI, advertising and marketing technology, media and entertainment, biotech, data analytics, and VR/AR. The portfolio has produced three unicorns, two IPOs, and 12 acquisitions. Notable investments include Mysten Labs (blockchain), GRAIL (cancer detection, acquired by Illumina), Twist Bioscience (synthetic biology, IPO), Kognitos (enterprise AI automation), and Skyflow (data privacy). Dentsu Ventures differentiates from independent VCs by offering portfolio companies direct access to Dentsu Group's global marketing capabilities, client relationships, and co-creation resources. Startups gain the dual benefit of financial backing and commercial acceleration through one of the world's most extensive advertising networks, making the firm particularly valuable to companies building in consumer-facing and enterprise software categories.

Beyond1435 is Deutsche Bahn's venture capital initiative that focuses on fostering innovation in the transportation and mobility sectors. Emerging from DB Digital Ventures in 2016, Beyond1435 has established itself as a key player in driving the future of rail and mobility technologies. The platform is dedicated to identifying and investing in early-stage startups that offer transformative solutions in areas like sustainability, production, and digital services. The firm partners with startups to develop technologies that align with Deutsche Bahn’s long-term goals of modernizing rail transport and enhancing operational efficiency. Beyond1435 supports startups through investment, collaboration, and access to Deutsche Bahn’s extensive global network. The firm focuses on technologies related to artificial intelligence, IoT, mobility, and smart cities. By fostering collaborations with external companies and setting up joint ventures, Beyond1435 strengthens not only Deutsche Bahn but also the wider mobility ecosystem. Its broad portfolio includes companies such as Brighter AI, Gideon Brothers, and Skyports, reflecting its commitment to advancing innovative technologies across sectors.

Deutsche Bank Corporate Venture Capital (CVC) is the global corporate venture program of Deutsche Bank AG, one of the world's leading financial institutions. Launched in 2020 with offices in Frankfurt, New York, and Berlin, the program is led by Jörg Landsch — Head of Central Corporate Venture Capital and a Deutsche Bank veteran since 2001 — alongside team member Milos Spiridnovic. The CVC takes strategic minority positions in early growth-stage companies, with average checks between $1 million and $10 million. With 44 investments and 12 exits to date, the portfolio concentrates on fintech, AI, ESG technology, cybersecurity, and cloud software. Notable portfolio companies include Deel (global HR and payroll platform), Kodex AI (financial data analytics), Plan A (carbon accounting), Akeyless (identity security), Axoni (distributed ledger infrastructure for capital markets), and Binalyze (digital forensics). Deutsche Bank is also an LP in High-Tech Gründerfonds, the German seed-stage fund. The CVC's investment thesis is explicitly strategic: Deutsche Bank targets companies that use technology to support or enable banking and financial services, as well as broader enterprise technology. AI and ESG are the two largest priority areas. The program partners with innovative startups to shape the future of financial services, giving portfolio companies access to Deutsche Bank's global client relationships and regulatory expertise alongside the capital investment.

DTCP (Digital Transformation Capital Partners) is an independent investment management firm founded in 2015. The firm focuses on two main investment strategies: Growth Equity and Digital Infrastructure. With over €2.2 billion in assets under management, DTCP has invested in more than 60 companies, supporting transformative technology leaders globally and digital infrastructure projects in Europe. DTCP's Growth Equity platform targets technology sectors such as cybersecurity, AI, fintech, and cloud-based enterprise software, aiming to accelerate digital transformation. Their notable portfolio includes investments in companies like Aryaka, NS1, and Heap. The firm’s data-driven investment approach and strong operational support help these companies scale effectively. In the Digital Infrastructure space, DTCP invests in mobile towers, fiber networks, and data centers. Key infrastructure investments include Swiss Towers, Community Fibre Limited, and Cellnex Netherlands. This strategy focuses on creating long-term value and supporting sustainable digital infrastructure development across Europe. The leadership team is headed by CEO Vicente Vento and includes Managing Partner Jack Young, who oversees the Growth platform, and Philipp von Bismarck, Managing Partner for the Digital Infrastructure Vehicle II. They bring extensive experience in technology investments and digital infrastructure projects. DTCP’s approach combines strategic capital investment with operational expertise, leveraging a strong network of industry relationships to drive growth and innovation in its portfolio companies.

Development Capital, established in 2013 and headquartered in Dublin, is an Irish growth capital fund manager focused on scaling mid-sized, profitable Irish SMEs with strong export potential. The firm typically invests between €2 million and €12 million in ambitious companies, using flexible financing structures such as equity, quasi-equity, or debt, and typically holds minority stakes with a five-year investment horizon. Development Capital is committed to supporting companies with growth strategies, ranging from international expansions to strategic acquisitions and production capacity increases. The fund’s €75 million Fund II, supported by the European Investment Fund and the Ireland Strategic Investment Fund, targets Irish SMEs poised for international growth. Notable portfolio companies include Version 1, a leading IT services provider, and Spotlight Oral Care, a premium oral care brand. Through their investments, Development Capital has helped companies like Perigord expand globally and develop new products. Perigord, a leader in life sciences packaging, was acquired by Tech Mahindra, allowing Development Capital to successfully exit its investment. The firm prides itself on offering more than just capital. It partners closely with management teams to maximize growth potential, bringing industry experience and market insights to every engagement. With a focus on responsible investing, Development Capital integrates ESG factors throughout its investment process, ensuring sustainable and impactful growth for its portfolio companies.

Dexcel Pharma is the largest private pharmaceutical company in Israel, renowned for its extensive portfolio of branded and generic drugs. Founded in 1968, the company has grown into a global player, with state-of-the-art R&D and manufacturing facilities that support the development and commercialization of innovative and cost-effective pharmaceutical products. Dexcel's product portfolio spans across various therapeutic areas, including small molecules, biologics, and RNA-based therapies. The company is committed to advancing science through substantial investments in R&D, particularly in cutting-edge fields like siRNA therapeutics and oligonucleotides. Their innovation initiatives include the creation of specialized entities like Dexoligo Therapeutics, which focuses on RNA-based medicines, and Clexio Biosciences, which develops treatments for neurological and psychiatric conditions. With over 1,200 employees and a strong presence in key markets like the United States, Germany, and the UK, Dexcel manufactures over 5 billion oral-solid dosages annually. The company maintains a reputation for quality, with its facilities meeting global standards and holding approvals from regulatory bodies like the FDA and EMA.

DHV Digital Health Ventures is a Berlin-based, sector-focused early-stage venture capital fund founded in 2015 by Ulli Jendrik Koop, dedicated to building a sustainable digital health ecosystem across Europe. The firm is managed by DHV Management GmbH and invests in young startups pioneering human-centric healthcare solutions primarily in Germany and other European markets, with additional activity in Scandinavia, Canada, and the US. DHV leads rounds and writes checks from $250,000 to $5 million across pre-seed through Series B stages, with approximately 10 investments and two exits to date. Portfolio companies include TeleClinic (telemedicine, acquired by Zur Rose Group in 2020), Wefight (chronic illness virtual assistant, for which DHV led an $11.8 million Series A), Liva Healthcare (digital chronic disease management used by NHS England), DrugStars (medicine review and donation platform), and Movn Health. Managing Partners Ulli Jendrik Koop, Guido Hegener (an early-stage digital health investor since 2013), and Min-Sung Sean Kim (formerly at Allianz X and Samsung Catalyst Fund) lead the investment team. DHV's investment thesis prioritizes digital health startups with attractive business models that leverage technology to improve patient outcomes. The firm draws on a strong network of experienced investors, clinicians, and healthcare operators, positioning it as more than a capital source — portfolio companies gain access to clinical validation pathways and commercial partnerships that are critical for scaling health technology businesses.

Diageo is a global leader in the beverage alcohol industry, headquartered in London, UK. Established in 1997 through the merger of Guinness PLC and Grand Metropolitan, the company has grown into a powerhouse, owning a vast portfolio of iconic brands across spirits, beer, and wine. Its flagship brands include Johnnie Walker, Guinness, Tanqueray, Smirnoff, and Baileys, which are enjoyed in over 180 countries. Diageo's business model focuses on premiumization, innovation, and sustainability. It operates in three major regions: North America, Europe, and Asia-Pacific, with North America being its largest market. The company continuously invests in expanding its product lines, with a particular emphasis on premium and ultra-premium categories. In recent years, Diageo has strengthened its position in the tequila market with brands like Don Julio and Casamigos. Sustainability and social responsibility are core to Diageo’s operations. The company is committed to reducing carbon emissions, water usage, and plastic waste across its production facilities, with ambitious goals set for 2030. Additionally, Diageo has a long history of promoting responsible drinking through campaigns and partnerships worldwide. Led by CEO Ivan Menezes, Diageo continues to focus on long-term growth by exploring new markets, embracing digital innovation, and investing in a diversified portfolio of brands that cater to evolving consumer preferences. The company’s strategy combines its rich heritage with forward-thinking initiatives, solidifying its position as a global leader in the spirits industry.

Diamond Capital is a venture capital firm based in Taiwan, primarily focusing on investments in the biotechnology, medical, and high-tech sectors. Established in 2013, the firm has built a strong reputation for nurturing innovative companies that are driving advancements in healthcare, new drug development, high-end medical equipment, and innovative medical services. Diamond Capital is known for its strategic investments that span early to growth-stage companies, particularly those operating in Asia. The firm is particularly noted for its involvement in the biotechnology sector, where it has been instrumental in supporting startups that have gone on to achieve significant milestones, including public listings. Diamond Capital's strategy involves not only providing capital but also leveraging its extensive network and expertise to guide companies through the complexities of scaling and entering global markets. This approach has made it a key player in Taiwan’s venture capital landscape. In 2023, Diamond Capital made headlines by becoming the first biotech venture capital firm to list on the Taiwan Stock Exchange, further enhancing its visibility and credibility on the international stage. The firm's portfolio includes a diverse array of companies, from cutting-edge biotech firms to innovative medical device manufacturers, all of which are united by their potential to make significant contributions to their respective fields.